Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Oligomerix, Inc in September, 2018 for $2,356,900.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG053150-03 | Phase II | 2,356,900 | September 30, 2018 | |||||||
A SBIR Phase II contract was awarded to Oligomerix, Inc in September, 2019 for $1,228,934.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG066384-01 | Phase II | 1,228,934 | September 30, 2019 | |||||||
A SBIR Phase II contract was awarded to Oligomerix, Inc in September, 2020 for $1,452,237.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG053150-05 | Phase II | 1,452,237 | September 15, 2020 | |||||||
A SBIR Phase II contract was awarded to Oligomerix, Inc in May, 2019 for $999,982.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AG062021-02 | Phase II | 999,982 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Oligomerix, Inc in September, 2018 for $499,433.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG062021-01 | Phase I | 499,433 | September 30, 2018 | |||||||
A SBIR Phase II contract was awarded to Oligomerix, Inc in September, 2022 for $1,124,972.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG077991-01A1 | Phase II | 1,124,972 | September 30, 2022 | |||||||
A SBIR Phase I contract was awarded to Oligomerix, Inc in September, 2017 for $302,112.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AG057325-01 | Phase I | 302,112 | September 1, 2017 | |||||||
A SBIR Phase II contract was awarded to Oligomerix, Inc in May, 2016 for $1,499,590.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG053150-01 | Phase II | 1,499,590 | May 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Oligomerix, Inc for $233,598.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AG029777-01 | Phase I | 233,598 | ||||||||
A SBIR Phase II contract was awarded to Oligomerix, Inc for $1,717,684.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AG029777-04 | Phase II | 1,717,684 | ||||||||
A SBIR Phase I contract was awarded to Oligomerix, Inc for $323,291.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AG033474-01 | Phase I | 323,291 | ||||||||
A SBIR Phase II contract was awarded to Oligomerix, Inc for $1,649,600.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AG029777-02A1 | Phase II | 1,649,600 | ||||||||
A SBIR Phase II contract was awarded to Oligomerix, Inc in August, 2023 for $1,496,276.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG066384-03 | Phase II | 1,496,276 | August 15, 2023 |